Blood Sugar and Nerve Damage: Why “Normal” Lab Work Misses It
Your fasting glucose came back normal. Your A1C was fine. And your feet still burn, the weight still will not move, and you still feel tired. Those things are not in conflict. A normal glucose tells you the late stage of a metabolic problem has not arrived yet — not that your metabolism is healthy.
Insulin Rises Years Before Blood Sugar Does
Insulin is the hormone that moves glucose out of the bloodstream. When cells stop responding to it well, the pancreas compensates by making more. Blood sugar stays normal, because the compensation is working. That compensation can run for a decade or longer, and it is during that decade that the damage to small vessels and small nerves begins.
By the time fasting glucose or A1C finally drifts upward, the compensation has been running a long time and has started to fail. The test has not caught the problem early. It has caught it late.
The Test Most Offices Run Was Not Built to Catch This
This is not a fringe position. In its Standards of Care, the American Diabetes Association states that A1C and glucose-tolerance testing “reflect different aspects of glucose metabolism” and will “identify groups with incomplete concordance,” and that compared with A1C, the two-hour tolerance value “diagnoses more people with prediabetes and diabetes”1. In other words, the body that sets the diagnostic standard says plainly that A1C and tolerance testing do not identify the same people, and that A1C identifies fewer of them.
The gap is not small. Research presented to the Endocrine Society comparing the two found that A1C missed almost 73% of people who met tolerance-test criteria for diabetes2 — people who would have been told they were fine.
A1C measures how much glucose has attached to hemoglobin over roughly three months. It is a good measure of the thing it measures. It is simply a late signal, and it says nothing at all about insulin.
What to Ask For Instead
A more complete picture does not require exotic testing. It requires ordering a few things together and reading them as a pattern:
- Fasting insulin, alongside fasting glucose — the single most useful addition, and the one most often left off
- Triglyceride-to-HDL ratio, calculated from a standard lipid panel you have probably already had
- A1C, kept in the picture but not read alone
- Waist circumference, which costs nothing and carries real information about visceral fat — see belly fat and insulin
None of these are unusual or expensive. They are simply not what a routine annual panel is built around.
Why This Matters for Your Feet
The smallest nerves are fed by the smallest blood vessels. Elevated insulin and glucose damage those vessels and stiffen the tissue around them through glycation — sugar binding to protein. The nerve is starved before it is lost.
That is the mechanical link between a metabolic problem you were told you did not have and a symptom you very much do. It is also why addressing the driver matters more than medicating the sensation. More on the symptom side at burning and numb feet.
Frequently Asked Questions
My A1C is normal. Can I still have a blood sugar problem?
Yes, and it is common. A1C reflects average glucose over about three months, and glucose is the last thing to move. Insulin resistance can run for years underneath a normal A1C. The American Diabetes Association itself notes that A1C and tolerance testing identify different groups. Our Nerve Damage Score is a starting point if you have symptoms.
What is the single most useful test to add?
Fasting insulin, drawn at the same time as fasting glucose. It is inexpensive, widely available, and it looks at the compensation rather than the failure. Paired with the triglyceride-to-HDL ratio from a lipid panel you likely already have, it changes the picture considerably. See belly fat and insulin for what elevated insulin does elsewhere in the body.
If I fix the blood sugar, will the nerve pain go away?
Addressing the driver is what gives the nerve a chance to recover, and small-fiber regrowth has been measured after diet and exercise intervention. But results vary by person and by how long the process has been running, and no honest clinic will promise you a specific outcome. Our resource library goes into what the evidence does and does not show.
References
- American Diabetes Association. Standards of Care in Diabetes — 2025, Section 2: Diagnosis and Classification of Diabetes. Diabetes Care 48(Suppl. 1):S27.
- Research presented to the Endocrine Society comparing A1C with oral glucose tolerance testing found A1C missed almost 73% of people who met tolerance-test criteria for diabetes.
Find Out Where You Stand
Five questions, about two minutes, no account needed.
Prefer to just ask a question? Call or text (314) 886-5902, or email info@regenerve.com. We are glad to talk through what is going on — there is no obligation and no pressure to become a patient. If you would rather read first, our Neuropathy Resource Library is free and there is nothing to sign up for.